NR 546 Advanced Pharmacology: Psychopharmacology for the Psychiatric-Mental Health Nurse
Practitioner - Summer 2025 Syllabus
NR 546 WEEK 4 MIDTERM EXAM 2025/2026 COMPLETE
QUESTION AND ANSWER 100% ACCURATE FALL-SPRING
A 76-year-old patient who is determined to be a poor 2D6 metabolizer is being
prescribed vortioxetine for his depression. What does the PMHNP need to remember
when prescribing this drug?
A. The dosage of the drug will need to be increased
B. The dosage needs to begin at half then increase over a 2-week period
C. The dosage should not exceed ½ of the usual recommended dose
D. An adjunct medication will need to be prescribed until the dosage can be reduced
C. The dosage should not exceed ½ of the usual recommended dose
Which of the following mechanisms would you associate with an antagonist drug
action?
A. A drug that binds postsynaptic receptors and mimics the effect of the
neurotransmitter.
B. A drug that binds and blocks normal auto receptor function.
C. A drug that increases the enzymatic synthesis of neurotransmitters.
D. A drug that binds postsynaptic receptors and blocks the normal action of the
neurotransmitter.
D. A drug that binds postsynaptic receptors and blocks the normal action of the
neurotransmitter.
,NR 546 Advanced Pharmacology: Psychopharmacology for the Psychiatric-Mental Health Nurse
Practitioner - Summer 2025 Syllabus
A court order inpatient hospitalization was ordered for a patient who is considered a
danger to themselves and other. Which ethical issue is being addressed?
A. Informed consent
B. Off labeling prescription
C. Compliance
D. Restrictive methods
C. Compliance
What is the expected outcome for a patient who is considered a "intermediate
metabolizer"?
A. No need for medication dosage readjustments
B. Increased risk for drug to drug reactions
C. Provider increasing drug dosages
D. Subtherapuetic drug levels
B. Increased risk for drug to drug reactions
Which of the following is true regarding epigenetic changes?
A. Epigenetic changes are reversible.
B. Epigenetic changes, changes the DNA and how the body reacts to the DNA
sequence.
C. Epigenetic changes are not linked to mental health conditions.
D. When combined with genetic risks, epigenetic changes decreased the risk for a
psychiatric disease.
A. Epigenetic changes are reversible.
, NR 546 Advanced Pharmacology: Psychopharmacology for the Psychiatric-Mental Health Nurse
Practitioner - Summer 2025 Syllabus
Which of the following brain structures is involved in voluntary motor movements?
A. Basal ganglia
B. Prefrontal cortex
C. Amygdala
D. Limbic system
A. Basal ganglia
A 22-year-old patient recently diagnosed with bipolar disorder and states "I'm not
crazy" and is refusing to take his prescribed medication. Which type of factor is
contributing to this patient's nonadherence?
A. Client factors
B. Clinician factors
C. Structural factors
D. Environmental factors
C. Structural factors
Using Dell'Osso et al.'s sequential framework of priorities to promote medication
adherence, determine which step is being defined: The PMHNP explains the
mechanism of action, anticipated time to experience effects, side effects, and lifestyle
instructions to a patient after prescribing Wellbutrin.
A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
B. Medication education
Practitioner - Summer 2025 Syllabus
NR 546 WEEK 4 MIDTERM EXAM 2025/2026 COMPLETE
QUESTION AND ANSWER 100% ACCURATE FALL-SPRING
A 76-year-old patient who is determined to be a poor 2D6 metabolizer is being
prescribed vortioxetine for his depression. What does the PMHNP need to remember
when prescribing this drug?
A. The dosage of the drug will need to be increased
B. The dosage needs to begin at half then increase over a 2-week period
C. The dosage should not exceed ½ of the usual recommended dose
D. An adjunct medication will need to be prescribed until the dosage can be reduced
C. The dosage should not exceed ½ of the usual recommended dose
Which of the following mechanisms would you associate with an antagonist drug
action?
A. A drug that binds postsynaptic receptors and mimics the effect of the
neurotransmitter.
B. A drug that binds and blocks normal auto receptor function.
C. A drug that increases the enzymatic synthesis of neurotransmitters.
D. A drug that binds postsynaptic receptors and blocks the normal action of the
neurotransmitter.
D. A drug that binds postsynaptic receptors and blocks the normal action of the
neurotransmitter.
,NR 546 Advanced Pharmacology: Psychopharmacology for the Psychiatric-Mental Health Nurse
Practitioner - Summer 2025 Syllabus
A court order inpatient hospitalization was ordered for a patient who is considered a
danger to themselves and other. Which ethical issue is being addressed?
A. Informed consent
B. Off labeling prescription
C. Compliance
D. Restrictive methods
C. Compliance
What is the expected outcome for a patient who is considered a "intermediate
metabolizer"?
A. No need for medication dosage readjustments
B. Increased risk for drug to drug reactions
C. Provider increasing drug dosages
D. Subtherapuetic drug levels
B. Increased risk for drug to drug reactions
Which of the following is true regarding epigenetic changes?
A. Epigenetic changes are reversible.
B. Epigenetic changes, changes the DNA and how the body reacts to the DNA
sequence.
C. Epigenetic changes are not linked to mental health conditions.
D. When combined with genetic risks, epigenetic changes decreased the risk for a
psychiatric disease.
A. Epigenetic changes are reversible.
, NR 546 Advanced Pharmacology: Psychopharmacology for the Psychiatric-Mental Health Nurse
Practitioner - Summer 2025 Syllabus
Which of the following brain structures is involved in voluntary motor movements?
A. Basal ganglia
B. Prefrontal cortex
C. Amygdala
D. Limbic system
A. Basal ganglia
A 22-year-old patient recently diagnosed with bipolar disorder and states "I'm not
crazy" and is refusing to take his prescribed medication. Which type of factor is
contributing to this patient's nonadherence?
A. Client factors
B. Clinician factors
C. Structural factors
D. Environmental factors
C. Structural factors
Using Dell'Osso et al.'s sequential framework of priorities to promote medication
adherence, determine which step is being defined: The PMHNP explains the
mechanism of action, anticipated time to experience effects, side effects, and lifestyle
instructions to a patient after prescribing Wellbutrin.
A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
B. Medication education
